Ceftazidime-Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development

• Main Authors: Miguel García-Boyano (Author), María Alós Díez (Author), Lorena Fernández Tomé (Author), Luis Escosa-García (Author), Francisco Moreno Ramos (Author), Cristina Schuffelmann-Gutiérrez (Author), Emilio Cendejas Bueno (Author), Cristina Calvo (Author), Fernando Baquero-Artigao (Author), Esteban Frauca Remacha (Author)
• Format: Book
• Published: MDPI AG, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The prevalence of multidrug-resistant Gram-negative infections, particularly carbapenem-resistant strains, has become a significant global health concern. Ceftazidime-avibactam (CZA) has emerged as a promising treatment option. However, data on its efficacy and safety in children are scarce, necessi...